Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil

Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil

Introduction: In recent years, new technologies – noticeably ultra-portable echocardiographic machines – have emerged, allowing for Rheumatic Heart Disease (RHD) early diagnosis. We aimed to perform a cost-utility analysis to assess the cost-effectiveness of RHD screening with handheld devices in th...

Full description

Bibliographic Details
Main Authors: Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento, On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators
Format: Article
Language:English
Published: Ubiquity Press 2020-02-01
Series:Global Heart
Subjects:
rheumatic heart disease
echocardiography
screening
cost-effectiveness
Online Access:https://globalheartjournal.com/articles/529

Internet

https://globalheartjournal.com/articles/529

Similar Items